Page 1 of Clinical Trials for basiliximab, 96 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Not yet recruiting
Pharmacodynamics, Efficacy, Safety of Basiliximab 40 or 80 mg Combined With CsA or Everolimus, in Low Risk de Novo Renal Transplant Recipients
Last Updated: March 1, 2012
Condition(s): Renal Transplantation
2
Recruiting
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
Last Updated: May 24, 2011
Condition(s): Reduction in Sequelae Related to Calcineurin Inhibitors; Chimeric Antibody Sensitization; Allograft Rejection
3
Recruiting
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Last Updated: May 8, 2012
Condition(s): Renal Transplantation
4
Completed
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
Last Updated: May 7, 2012
Condition(s): Kidney Transplantation; Adverse Effects
5
Completed
Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative Steroids
Last Updated: August 17, 2011
Condition(s): Liver Transplantation; Infection
6
Completed
Basiliximab in Moderate to Severe Ulcerative Colitis
Last Updated: December 17, 2008
Condition(s): Ulcerative Colitis
7
Terminated
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Last Updated: August 17, 2010
Condition(s): Non-infectious Uveitis
8
Terminated
Basiliximab Maintenance in Ulcerative Colitis
Last Updated: February 2, 2010
Condition(s): Ulcerative Colitis
9
Not yet recruiting
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Last Updated: December 2, 2011
Condition(s): Graft Versus Host Disease; Steroid Refractory GVHD; Acute GVH Disease
10
Not yet recruiting
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Last Updated: November 18, 2011
Condition(s): Recurrent Adult Hodgkin Lymphoma
11
Completed
Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft Recipients
Last Updated: August 24, 2010
Condition(s): Pediatric Kidney Transplantation
12
Completed
Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients
Last Updated: December 12, 2006
Condition(s): Corneal Transplantation
13
Recruiting
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
Last Updated: June 9, 2011
Condition(s): Kidney Transplant
14
Active, not recruiting
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer
Last Updated: May 15, 2012
Condition(s): Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Myelodysplasia; Non-Hodgkin's Lymphoma; Hodgkin's Disease; Multiple Myeloma; Myelofibrosis; Anemia, Aplastic; Hemoglobinuria, Paroxysmal
15
Completed
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Last Updated: August 10, 2011
Condition(s): Kidney Transplantation
16
Completed
Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver Transplantation
Last Updated: August 31, 2010
Condition(s): Liver Transplant
17
Completed
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.
Last Updated: August 24, 2010
Condition(s): Liver Transplantation
18
Completed
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients
Last Updated: March 28, 2011
Condition(s): Organ Transplantation, Renal Transplantation
19
Recruiting
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
Last Updated: December 21, 2011
Condition(s): Liver Transplantation
20
Active, not recruiting
Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
Last Updated: September 8, 2011
Condition(s): Brain and Central Nervous System Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=basiliximab

Page 1 of Clinical Trials for basiliximab, 96 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About